Jardiance (Empagliflozin) and Finasteride Interaction
Clinical review of the drug interaction between empagliflozin (Jardiance) and finasteride, covering CYP metabolism, pharmacodynamic overlap, monitoring parameters, and dose-adjustment guidance.
Empagliflozin: Drug Interactions
29 source-based articles maintained by the HealthRX.com Editorial Team.
29articles
3topic areas covered
May 25, 2026latest review
Empagliflozin: Drug Interactions library
Showing 29 of 29 clinical reviews.
Jardiance (Empagliflozin) and Rivaroxaban Interaction: Safety, Risks, and Monitoring
Clinical analysis of the empagliflozin-rivaroxaban drug interaction covering pharmacokinetic mechanisms, bleeding risk, volume depletion, renal monitoring, and dose-adjustment guidance.
Jardiance and Acetaminophen Interaction: Safety, Risks, and Clinical Guidance
Is it safe to take Jardiance (empagliflozin) with acetaminophen? A guide covering pharmacokinetic data, hepatic considerations, monitoring parameters, and dose-adjustment recommendations.
Jardiance and Apixaban Interaction: What Patients and Clinicians Need to Know
A clinician-level review of the empagliflozin (Jardiance) and apixaban drug interaction: mechanism, severity, monitoring parameters, dose-adjustment guidance, and patient counseling tips backed by primary literature.
Jardiance and Atorvastatin Interaction: What the Evidence Actually Shows
A clinical review of the empagliflozin-atorvastatin drug interaction, covering metabolic pathways, shared use in type 2 diabetes, monitoring considerations, and what remains unverified.
Jardiance and Benzodiazepines Interaction: What Clinicians and Patients Need to Know
A detailed clinical review of the pharmacokinetic and pharmacodynamic interaction between empagliflozin (Jardiance) and benzodiazepines, including mechanism, severity, monitoring, and patient counseling.
Jardiance and Bupropion Interaction: What Patients and Clinicians Need to Know
A guide to the empagliflozin, bupropion drug interaction covering CYP2D6 pharmacokinetics, seizure-threshold effects, hypoglycemia risk, and practical monitoring steps.
Jardiance and Clopidogrel Interaction: What Patients and Clinicians Need to Know
A complete clinical review of the empagliflozin-clopidogrel drug interaction: mechanism, severity, CYP2C19 pharmacology, monitoring parameters, and patient counseling guidance.
Jardiance and Diphenhydramine Interaction: What Clinicians and Patients Should Know
Evidence-based review of the empagliflozin (Jardiance) and diphenhydramine interaction, covering CYP metabolism, anticholinergic risk, blood glucose effects, and clinical monitoring recommendations.
Jardiance and Estradiol HRT Interaction: Safety, Monitoring, and Clinical Evidence
Evidence-based guide to the empagliflozin, estradiol HRT combination covering pharmacokinetic and pharmacodynamic considerations, what is established versus unproven, and monitoring guidance pending qualified clinical review.
Jardiance and Gabapentin Interaction: What the Evidence Shows
Clinical review of the empagliflozin (Jardiance) and gabapentin interaction covering pharmacokinetic overlap, renal dosing, monitoring, and safety data.
Jardiance and Hormonal Contraceptives: Drug Interaction Guide
Can you take Jardiance (empagliflozin) with hormonal contraceptives? A look at the mechanism, what the FDA label says, what remains unverified, and what to monitor when using both.
Jardiance and Metformin Interaction Explained
No drug-drug interaction exists between Jardiance and metformin, but declining kidney function raises metformin accumulation risk. Learn what to watch for.
Jardiance and NSAIDs (Ibuprofen, Naproxen) Interaction
Clinical guide to the empagliflozin and NSAID interaction, covering renal risk, mechanism, monitoring, dose adjustment, and safe alternatives for pain relief.
Jardiance and Opioids (Oxycodone, Hydrocodone, Tramadol): Interaction Guide
Clinical review of empagliflozin (Jardiance) interactions with opioids including oxycodone, hydrocodone, and tramadol. Covers pharmacokinetic and pharmacodynamic mechanisms, monitoring, and dose adjustment.
Jardiance and PPIs (Omeprazole, Pantoprazole): Drug Interaction Guide
Can you take Jardiance (empagliflozin) with omeprazole or pantoprazole? Review of CYP/UGT metabolism, P-gp transport, shared electrolyte risks, and monitoring recommendations.
Jardiance and Prednisone Interaction: What Clinicians and Patients Should Know
Empagliflozin (Jardiance) and prednisone have opposing effects on blood glucose. What is established, what is plausible but unproven, and what a clinician or pharmacist should verify before combining them.
Jardiance and Pregabalin Interaction: What Patients and Prescribers Need to Know
A clinical deep-dive into the empagliflozin-pregabalin drug interaction: pharmacokinetic mechanisms, pharmacodynamic risks, monitoring parameters, and patient counseling guidance backed by primary literature.
Jardiance and Progesterone HRT Interaction: Safety, Risks, and Monitoring
Can you take Jardiance (empagliflozin) with progesterone HRT? A guide to the pharmacology, the evidence that exists and does not exist, and what to verify before combining them.
Jardiance and Rosuvastatin Interaction: What Patients and Clinicians Need to Know
A clinical review of the empagliflozin-rosuvastatin drug interaction, covering pharmacokinetic mechanisms, severity ratings, monitoring recommendations, and dose-adjustment guidance.
Jardiance and Sildenafil Interaction: Safety, Mechanisms, and Clinical Guidance
Evidence-based review of the empagliflozin (Jardiance) and sildenafil drug interaction, covering pharmacokinetic and pharmacodynamic mechanisms, blood pressure monitoring, and dose adjustment recommendations.
Jardiance and Simvastatin Interaction: Safety, Metabolism, and Clinical Guidance
A review of the empagliflozin, simvastatin combination covering metabolic pathways, what monitoring is actually needed, and where the evidence is solid versus where it is plausible but unconfirmed.
Jardiance and SNRIs (Venlafaxine, Duloxetine): Drug Interaction Guide
Clinical review of the empagliflozin (Jardiance) and SNRI (venlafaxine, duloxetine) interaction covering pharmacokinetic pathways, blood pressure effects, hyponatremia risk, blood glucose changes, and monitoring recommendations.
Jardiance and SSRIs (Sertraline, Escitalopram): Drug Interaction Guide
Clinical review of empagliflozin (Jardiance) interactions with SSRIs like sertraline and escitalopram, covering pharmacokinetic data, glucose effects, hyponatremia risk, and monitoring protocols.
Jardiance and Tadalafil Interaction: Safety, Risks, and Clinical Guidance
Can you take Jardiance (empagliflozin) with tadalafil? Review the pharmacokinetic and pharmacodynamic interaction profile, blood pressure effects, monitoring parameters, and dose-adjustment guidance backed by FDA labels and primary literature.
Jardiance and Testosterone Interaction: Safety, Monitoring, and Clinical Evidence
Can you take Jardiance (empagliflozin) with testosterone? A guide covering pharmacokinetic and pharmacodynamic interactions, monitoring protocols, and dose-adjustment considerations.
Jardiance and Trazodone Interaction: What Prescribers and Patients Should Know
A clinical deep-dive into the empagliflozin-trazodone interaction covering CYP metabolism, pharmacodynamic overlap, hypotension risk, monitoring protocols, and dose-adjustment guidance.
Jardiance and Warfarin Interaction: What Patients and Clinicians Need to Know
A guide to the empagliflozin and warfarin interaction: mechanism, severity, INR monitoring, dose considerations, and patient counseling based on FDA labeling and primary literature.
Jardiance and Zolpidem Interaction: Safety, Risks, and Clinical Guidance
Is it safe to take Jardiance (empagliflozin) with zolpidem? Review the pharmacokinetic and pharmacodynamic data, real risks, monitoring steps, and dose considerations for this combination.